Figure S3 from Tumor Microenvironment Composition and Severe Cytokine Release Syndrome (CRS) Influence Toxicity in Patients with Large B-Cell Lymphoma Treated with Axicabtagene Ciloleucel
Open Access
- 31 March 2023
- other
- Published by American Association for Cancer Research (AACR)